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Prevention of malaria and other mosquito-borne diseases 
depends  in  large  part  on  vector  control  and  usually 
involves  the  use  of  insecticides.  Insecticide-based 
methods  include  insecticide-impregnated  bed  nets,  as 
well as more obvious applications such as indoor or aerial 
sprays  and  water  treatments.  However,  the  emergence 
and spread of insecticide resistance poses a serious threat 
to the sustainability of current control efforts [1], with 
several  insecticide  classes  already  showing  reduced 
efficacy in controlling disease vectors in the field. Thus, 
there  is  a  clear  and  urgent  need  for  improving  the 
sustain  ability of current insecticide-based control inter-
ventions  as  well  as  for  exploring  alternative,  non-
insecticidal methods for controlling major vectors.
Identification of the factors influencing the selection of 
insecticide  resistance  is  an  important  prerequisite  for 
managing insecticide resistance. A recent study in BMC 
Genomics  by  David  et  al.  [2]  employs  next-generation 
sequencing  methods  to  analyze  the  transcriptional 
response of the mosquito Aedes aegypti, the vector of the 
dengue  virus,  to  xenobiotics  (manmade  chemicals) 
poten  tially present in its aquatic habitat. Studies such as 
this may ultimately lead to novel strategies to overcome 
resistance in the field.
Insecticide-resistance mechanisms
Insecticide  resistance  is  typically  characterized  by  a 
variety of molecular aberrations, such as transcriptional 
changes, gene amplification and point mutations in coding 
regions,  which  result  in  increased  rates  of  insecticide 
detoxification  or  reduced  sensitivity  of  the  target 
protein(s).  Analysis  of  mRNA  has  provided  significant 
insights into the molecular basis of resistance. Over the 
years, research in the field has progressed from analysis 
of a small number of candidate genes to high-throughput 
expression profiling driven by the advent of microarrays.
Specific microarray platforms, known as Detox Chips, 
have  been  developed  for  the  analysis  of  resistance 
mechanisms  in  mosquitoes  [3].  These  targeted  micro-
array platforms and whole-genome arrays have identified 
a  number  of  candidate  insecticide-resistance  genes. 
These include detoxification enzymes [3], some of which 
have been confirmed to metabolize insecticides [4] and 
have become targets for the design of inhibitors aimed at 
inactivating insecticide-metabolizing enzymes in natural 
populations. Several other genes, such as those involved 
in formation of the insect cuticle and those involved in 
the  mitochondrial  respiratory  chain,  have  also  been 
associated  with  the  resistance  phenotype  [3-5]  but  a 
causal role has not yet been demonstrated in mosquitoes.
An important limitation of microarray technology for 
studying insecticide resistance is its inability to identify 
mutations  in  detoxification  enzymes  that  may  confer 
resistance  by  altering  the  metabolic  efficiency  of  the 
enzyme for insecticides. Although only a few cases have 
been documented in the literature (reviewed in [6]), Chiu 
et al. [7] have shown that P450 cytochromes that are very 
similar  in  sequence  can  have  dramatically  different 
insecticide-metabolism profiles, and the authors suggest 
that a systematic analysis for allelic variants is essential. 
The advent of next-generation sequencing provides new 
opportunities  for  transcriptomic  studies  of  insecticide-
resistance mechanisms. Transcripts from susceptible and 
resistant insects can be compared to identify sequence 
polymorphisms and, provided sufficient sequence depth 
is achieved, quantitative data on transcript levels in the 
different populations can be obtained.
The importance of exposure to sublethal concentrations 
of  insecticides  in  inducing  resistance  remains  contro-
versial. Most conventional insecticides act very rapidly 
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enzymes will play an important part in determining the 
fate of the insect upon exposure to a pyrethroid-treated 
net.  However,  exposure  to  sublethal  concentrations  of 
insecticides  or  other  xenobiotics  in  the  larval  habitats 
undoubtedly  plays  an  important  part  in  shaping  the 
larval, and perhaps the adult, mosquitoes’ tolerance to 
insecticides. To investigate this response, David et al. [2] 
sequenced the entire transcriptome of Ae. aegypti larvae 
from populations exposed to different xenobiotics during 
their development. They showed that a large number of 
genes  (including  those  encoding  transporters,  and 
enzymes involved in the mitochondrial respiratory chain 
and detoxification processes) were affected in a general 
response - defined as ‘all proteins over-produced due to 
environmental stress’ [2] - to some xenobiotics (such as 
the  insecticides  propoxur  and  fluoranthene)  and  in  a 
more  specific  response  (smaller  number  of  affected 
genes) to others (permethrin, atrazine and copper). The 
authors  suggest  that  their  findings  indicate  a  ‘hidden 
impact’ of anthropogenic pollutants on ecosystems with 
possible  consequences  and  practical  implications  for 
vector control.
Next-generation sequencing technologies in 
disease vector control research
Next-generation  sequencing  has  revolutionized  trans-
crip  tome analysis by providing genome-wide expression 
profiles that are both quantitative and precise, affording 
single-nucleotide  resolution  of  differences  between 
sequences [8]. In essence, RNA (converted into cDNA) is 
sequenced in massively parallel sequencing instruments 
such that the number of times a sequence is represented 
in the output sequence data represents its relative abun-
dance in the input RNA - in other words its expression 
level. Transcriptome analysis by this method has some 
significant  advantages  over  microarray  platforms 
(Figure  1),  including  analysis  of  polymorphisms  in  the 
coding  sequence  and  the  ability  to  detect  novel 
transcripts. David et al. [2] identified a large number of 
sequence clusters not located within predicted genes in 
the  Ae.  aegypti  genome,  which  possibly  indicate  novel 
alternative  splice  junctions  and  transcriptional  units. 
However,  accurate  estimates  of  low-abundance  trans-
cripts  and  the  analysis  of  exon  polymorphism  become 
apparent only if sequencing depth is sufficient, and this 
requirement  dramatically  increases  the  cost  of  the 
sequencing.  In  addition,  a  sophisticated  information-
tech  nology infrastructure is required. The cost and data-
processing  requirements  make  it  unlikely  that  next-
generation  sequencing  will  replace  microarrays  as  the 
routine  tool  for  expression  profiling  in  disease  vector 
control applications in the short term, even in a research 
context.
Transcriptomics has applications to vector control that 
extend beyond understanding and managing insecticide 
resistance. One is in the area of genetic control strategies - 
the use of genetically engineered mosquitoes to reduce 
disease  transmission.  There  are  several  types  of 
approaches  to  this  [9],  but  all  require  exogenous 
sequences to be expressed at a predetermined time, place 
and/or level in the mosquito. But although there are a 
large number of such times, places and levels of interest 
to  mosquito  genetic  engineers,  there  are  very  few 
characterized promoters and other control elements with 
the necessary specificity. To develop a strain for a ‘sterile-
male’ genetic control system [10], Fu et al. [11] used sex-
specific alternative splicing, and the ‘tet-off’ gene-expres-
sion system, in combination with a promoter identified 
via subtractive hybridization of cDNAs. This was used to 
give  sex-  and  tissue-specific  expression  of  an  effector 
molecule  and,  by  design,  a  phenotype  of  repressible 
female-specific  flightlessness.  Next-generation  sequen-
cing could greatly facilitate the identification of suitable 
transcripts leading to potentially useful promoters, and 
also of alternative splicing systems. More generally, the 
potential value of systematic analysis is clear from on-
going work in Drosophila melanogaster. Release FB2010_03 
Figure 1. The contribution of transcriptional profiling 
approaches in insecticide-resistance research for improving 
the sustainability of insecticide-based disease vector control 
interventions. NGS, next-generation sequencing; SNP, single-
nucleotide polymorphism.
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Page 2 of 3of  FlyBase  [12]  includes  genome-wide  transcription 
profiles  at  multiple  developmental  stages.  Expression 
profiles, transcription start and stop sites, and alternative 
splicing  patterns  can  all  be  inferred  from  these  data. 
Furthermore, even though Drosophila already had one of 
the best annotated of all metazoan genomes, trans  crip-
tomics based on next-generation sequencing has revealed 
numerous  new  or  incorrectly  annotated  transcription 
units.
Although  next-generation  sequencing  might  improve 
the  quality  of  transcriptome  profiling  in  the  medium 
term, switching to novel technologies should not be seen 
as  a  magic  bullet,  however.  Progress  in  vector-control 
research is just as often hindered by inappropriate study 
design and data interpretation as by technical issues. For 
example, differential gene expression between insecticide-
resistant and susceptible mosquitoes may reflect different 
geographical origins and/or genetic background, and not 
be related to the resistance phenotype. The new sequen-
cing  technologies  are  clearly  a  great  addition  to  the 
available tools in vector-control research. The challenge 
will be how to use them to generate biologically meaning-
ful  data  and  clear  interpretations  to  drive  follow-up 
experimentation, rather than producing piles of data as 
an  alternative  to  thinking.  The  full  potential  of 
sequencing-based transcriptomics will be seen when it is 
used sensibly in combination with additional functional 
genomics  approaches  to  validate  predictions  that  arise 
from these datasets.
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